Arcutis Biotherapeutics (ARQT) Selling, General & Administrative (2019 - 2026)
Arcutis Biotherapeutics (ARQT) reported Selling, General & Administrative of $82.14 million for Q2 2026, up 18.7% from $69.17 million a year earlier and up 10.9% from the prior quarter.
Powered by 
Analysis
Arcutis Biotherapeutics (ARQT) Selling, General & Administrative (2019 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Arcutis Biotherapeutics' Selling, General & Administrative came in at $297.6 million, up 19.2% year-over-year; for FY2025, it came in at $274.55 million, up 19.7% from FY2024.
- Selling, General & Administrative has increased for seven consecutive years, with a five-year compound annual growth rate of 66.7% (FY2020 to FY2025).
- By year, Selling, General & Administrative came in at $229.39 million in FY2024 (+23.9%), $185.15 million in FY2023 (+51.6%), $122.12 million in FY2022 (+100.3%) and $60.97 million in FY2021 (+185.8%).
- The Q2 2026 figure ranks as the highest quarterly Selling, General & Administrative in data going back to Q1 2019.
- Year over year, Selling, General & Administrative has now increased in each of the last 26 quarters, with growth averaging 19.4% over the last eight quarters.
- Across the past five years, year-over-year growth in Selling, General & Administrative ran from 6.1% in Q3 2025 to 196.3% in Q3 2021.
- Per Business Quant data, the three quarters before Q2 2026 came in at $74.08 million (Q1 2026), $78.98 million (Q4 2025) and $62.4 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Arcutis Biotherapeutics | 3.18 Bn | 2.46 Bn | 118.92 Mn | 82.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 82.14 Mn |
| Mar 31, 2026 | 74.08 Mn |
| Dec 31, 2025 | 78.98 Mn |
| Sep 30, 2025 | 62.40 Mn |
| Jun 30, 2025 | 69.17 Mn |
| Mar 31, 2025 | 64.00 Mn |
| Dec 31, 2024 | 57.61 Mn |
| Sep 30, 2024 | 58.82 Mn |
| Jun 30, 2024 | 58.17 Mn |
| Mar 31, 2024 | 54.79 Mn |
| Dec 31, 2023 | 48.67 Mn |
| Sep 30, 2023 | 47.60 Mn |
| Jun 30, 2023 | 45.96 Mn |
| Mar 31, 2023 | 42.92 Mn |
| Dec 31, 2022 | 37.02 Mn |
| Sep 30, 2022 | 35.47 Mn |
| Jun 30, 2022 | 27.62 Mn |
| Mar 31, 2022 | 22.01 Mn |
| Dec 31, 2021 | 18.73 Mn |
| Sep 30, 2021 | 16.47 Mn |
API Access
Arcutis Biotherapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ARQT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "ARQT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ARQT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();